Use your antibodies-online credentials, if available.
Keine Produkte auf Ihrer Vergleichsliste.
Ihr Warenkorb ist leer.
Alle Spezies anzeigen
Weitere Synonyme anzeigen
Wählen Sie die Spezies und Applikation aus
anti-Human APOC1 Antikörper:
anti-Rat (Rattus) APOC1 Antikörper:
anti-Mouse (Murine) APOC1 Antikörper:
Sie gelangen zu unserer vorgefilterten Suche.
Human Monoclonal APOC1 Primary Antibody für ELISA, WB - ABIN559900
Meunier, Russell, Engle, Faulk, Purcell, Emerson: Apolipoprotein c1 association with hepatitis C virus. in Journal of virology 2008
Show all 3 Pubmed References
Human Polyclonal APOC1 Primary Antibody für ELISA, IHC - ABIN4281201
Berbée, van der Hoogt, Sundararaman, Havekes, Rensen: Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL. in Journal of lipid research 2005
Human Polyclonal APOC1 Primary Antibody für IHC (p), IP - ABIN152922
Sun, Lin, Lee, Wang, Cheng, Wu, Chang, Lai, Shieh, Young: Very low-density lipoprotein/lipo-viro particles reverse lipoprotein lipase-mediated inhibition of hepatitis C virus infection via apolipoprotein C-III. in Gut 2013
apoC-I and apoC-III (zeige APOC3 Antikörper) inhibit lipolysis by displacing LPL (zeige LPL Antikörper) from lipid emulsion particles. We also propose a role for these apolipoproteins in the irreversible inactivation of LPL (zeige LPL Antikörper) by factors such as angptl4 (zeige ANGPTL4 Antikörper).
ApoC-I polymorphism might be one of the genetic factors of longevity in Bama; the ApoC-I rs4420638 and rs584007 SNPs are associated with serum triglycerides and high-density lipoprotein-cholesterol levels in the longevous population
Among white women, three single nucleotide polymorphisms (SNPs) (rs2075650 [TOMM40 (zeige TOMM40 Antikörper)], rs4420638 [APOC1], and rs429358 [APOE (zeige APOE Antikörper)]) were significantly associated with survival to 90 years after correction for multiple testing (p < .001); rs4420638 and rs429358 were also significantly associated with healthy aging (p = .02). In African American women, no SNP was associated with longevity. In Hispanic women, 7 SNPs in linkage dise
APOC1 expression induces glomerulosclerosis, potentially by increasing the cytokine response in macrophages.
apoC-I inhibited in situ LPL (zeige LCP1 Antikörper) activity in adipocytes in both a concentration- and time-dependent manner. There was no change in postprandial WAT apoC-I secretion. WAT apoC-I secretion may inhibit WAT LPL (zeige LCP1 Antikörper) activity and promote delayed chylomicron clearance in overweight and obese subjects
People with allelic variation in four genes related to cardiovascular diseases and metabolism were more likely to die: apolipoprotein (APO (zeige C9orf3 Antikörper))C1 GG and AG carriers, APOE (zeige APOE Antikörper) varepsilon4 carriers, insulin-degrading enzyme (IDE (zeige IDE Antikörper)) TC carriers, and phosphatidylinositol 3-kinase (PI3KCB) GG carriers.
Common single-nucleotide polymorphism in the APOC1/APOE (zeige APOE Antikörper) region, previously found to be associated with protective levels of cholesterol and lower cardiovascular risk, may be associated with ideal health.
These findings indicated that variants in TOMM40 (zeige TOMM40 Antikörper)/APOE (zeige APOE Antikörper)/APOC1 region might be associated with human longevity. Further studies are needed to identify the causal genetic variants influencing human longevity.
These results suggest that ApoC-I peptides may be a potential diagnostic biomarker and therapeutic approach for breast cancer.
APOC1 SNP is associated with the A beta (zeige SUCLA2 Antikörper)-42 levels in CSF (zeige CSF2 Antikörper).
This sbioinformatics analysis explored the shared genetic etiology underlying Type 2 Diabetes and Alzheimer's Disease on SNP level, gene level, and pathway level. Six SNPs on APOC1 gene.
Apolipoprotein C-I was significantly increased in obese mice plasma.
The absence of ApoC-I results in impaired memory functions, which is, together with previous data, suggestive of an important, bell-shaped gene-dose dependent role for ApoC-I in appropriate brain functioning
Data show that the stimulating effect of apoCI on the lipopolysaccharide (LPS (zeige TLR4 Antikörper))response resembles that of LPS-binding protein (LBP (zeige LBP Antikörper)) and depends on CD14 (zeige CD14 Antikörper)/ Toll-like receptor 4 (zeige TLR4 Antikörper) signaling.
present observations provide direct support for a potent specific inhibition of CETP (zeige CETP Antikörper) by plasma apoCI in vivo
The apoC-I content of lipoprotein remnants may serve as an early marker of coronary artery disease risk.
TR4 (zeige NR2C2 Antikörper) can also regulate apolipoprotein E (zeige APOE Antikörper), C-I, and C-II gene expression via the TR4 (zeige NR2C2 Antikörper) response element within the hepatic control region
apoC-I is a potent inhibitor of LPL (zeige LPL Antikörper)-mediated triglyceride lipolysis
irrespective of receptor-mediated remnant clearance by the liver, liver-specific expression of recombinant human apoCI causes hypertriglyceridemia in the absence of the VLDLr (zeige VLDLR Antikörper) and apoCIII (zeige APOC3 Antikörper) in mice
Endogenous apoC-I increases hyperlipidemia in apoE (zeige APOE Antikörper)-knockout mice by stimulating VLDL production and inhibiting LPL (zeige LPL Antikörper).
Cholesteryl ester transfer protein (zeige CETP Antikörper) is the sole major determinant of cholesteryl ester transfer in normolipidemic rabbit plasma as a result of the inability of rabbit apoCI to change HDL (zeige HSD11B1 Antikörper) electronegativity.
The protein encoded by this gene is a member of the apolipoprotein C1 family. This gene is expressed primarily in the liver, and it is activated when monocytes differentiate into macrophages. A pseudogene of this gene is located 4 kb downstream in the same orientation, on the same chromosome. This gene is mapped to chromosome 19, where it resides within a apolipoprotein gene cluster. Alternatively spliced transcript variants have been found for this gene, but the biological validity of some variants has not been determined.
, Apolipoprotein C-I
, apolipoprotein C1
, liver regeneration-related protein LRRG04